Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001415889-24-007091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-06 | 2024-03-04 | AMPH | Liawatidewi Yakob | EVP CORP ADMIN CENTER, Dir | A - Grant | $0.00 | +10.8K | 80.4K | +15% | $0 |
| D | 2024-03-06 | 2024-03-04 | AMPH | Liawatidewi Yakob | EVP CORP ADMIN CENTER, Dir | A - Grant | $0.00 | +22.7K | 22.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | A | A | 10,754 | $0.00 | 80,423 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 4, 2025. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-03-04 | A | A | 22,655 | $0.00 | 22,655 | D | $46.68 · — to 2034-03-04 | 22,655 Common Stock | (F3) The shares subject to the option vest in four equal annual installments beginning on March 4, 2025. |